TH Theratechnologies Inc.

Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020

Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020

MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences.

B. Riley Securities Liver Disease Therapeutics Day

  • Thursday, October 29, 2020
  • Panel discussion with Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer

29th Annual Credit Suisse Healthcare Conference

  • Tuesday, November 10, 2020, 8:45 a.m. ET
  • Presentation by Paul Levesque, President and Chief Executive Officer

To access the virtual events, please visit the ‘News’ section of the Company’s website. The webcast details will be posted one day before the event date.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at , on SEDAR at and on EDGAR at .

For media inquiries:

Denis Boucher

Vice-President, Communications and Corporate Affairs

514-336-7800

For investor inquiries:

Leah Gibson

Senior Director, Investor Relations

 

617-356-1009

EN
22/10/2020

Underlying

THTheratechnologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Theratechnologies Inc.

 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies reçoit l’approbation définitive du tribunal relative...

Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak MONTRÉAL, 16 sept. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade de la commercialisation, a annoncé aujourd’hui que la Société a obtenu l’ordonnance définitive de la Cour supérieure du Québec (chambre commerciale) approuvant le plan d’arrangement (l’« Arrangement ») pris en vertu du chapitre XVI – section II de la Loi sur les sociétés par ...

September 16, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Receives Final Court Approval of Proposed Plan of Ar...

Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak MONTREAL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today that the Company has obtained the final order from the Superior Court of Québec (Commercial Division) approving the previously-announced plan of arrangement (the “Arrangement”) under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Pu...

September 16, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to...

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak MONTREAL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that its shareholders have approved the previously announced plan of arrangement (the “Arrangement”) under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”). At the special meetin...

September 12, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Les actionnaires de Theratechnologies approuvent le plan d’arrangement...

Les actionnaires de Theratechnologies approuvent le plan d’arrangement proposé visant l’acquisition de la Société par Future Pak MONTRÉAL, 12 sept. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade de la commercialisation, est heureuse d’annoncer que ses actionnaires ont approuvé le plan d’arrangement (l’« Arrangement ») pris en vertu du chapitre XVI – section II de la Loi sur les sociétés par actions (Québec) annoncé précédemment et auquel est partie CB Biotechnology, LLC (l’« Acqué...

September 12, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) ...

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV® Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the availability of EGRIFTA WR™ (tesamorelin) for injecti...

September 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch